The University of North Texas Health Science Center and The Center for Cancer and Blood Disorders have formed the Institute for Cancer and Blood Disorders. The new Institute's goal is to eliminate cancer through excellence in research, prevention, patient care, education and service to cancer patients and families in both urban and rural Texas.
The new Institute for Cancer and Blood Disorders is a unique academic-community collaboration of more than 50 researchers and clinicians that creates a truly integrated cancer center in North Texas. Patients at The Center's existing seven Metroplex locations will continue to receive all-encompassing cancer care, including medical oncology, radiation oncology, CyberKnife, hematology, social services, laboratory, radiology, a host of integrative medicine options and clinical trials. The Health Science Center will supplement this cancer care with advanced laboratory research, nationally recognized physician training and public health education.
The two organizations have a long history of working together to train medical students. The new institute will address the growing shortage of oncologists by providing more community-based fellowships for oncology education and offering additional oncology training for primary care physicians. It also offers a united organization for pursuing research funding.
"We have been doing laboratory research on cancer for decades, and The Center has been doing clinical trials for more than 10 years," Dr. Scott Ransom, Health Science Center president, said. "Now together our organizations can translate bench research and take it to the bedside to directly help patients."
"The Institute's mission is simple, really. We want to cure cancer by combining the huge knowledge base and expertise of the Health Science Center with the highly experienced cancer specialists, technology and comprehensive services provided by The Center for Cancer and Blood Disorders," Dr. Bill Jordan said. "With the expertise of Fort Worth's two medical leaders and our combined research focus on cancer prevention and cure, we can make that happen."
William Jordan, DO, Executive Director
Greg Friess, DO, Director for Cancer & Blood Disorders
Jamboor Vishwanatha, PhD, Director for Cancer & Blood Disorders and Basic Science Research
Ray Page, DO, PhD, Director of Clinical Research
Sanjay Awasthi, MD, Director of Cancer Prevention and Outreach
If you are with the media and need additional information or would like to arrange an interview,
please contact Jeff Carlton, Director of Media Relations, at 817-735-7630.